213 related articles for article (PubMed ID: 17462502)
21. Minor transplantation antigens: mouse models for human host-versus-graft, graft-versus-host and graft-versus-leukemia reactions.
Simpson E
Arch Immunol Ther Exp (Warsz); 1998; 46(6):331-9. PubMed ID: 9883311
[TBL] [Abstract][Full Text] [Related]
22. The human cathepsin H gene encodes two novel minor histocompatibility antigen epitopes restricted by HLA-A*3101 and -A*3303.
Torikai H; Akatsuka Y; Miyazaki M; Tsujimura A; Yatabe Y; Kawase T; Nakao Y; Tsujimura K; Motoyoshi K; Morishima Y; Kodera Y; Kuzushima K; Takahashi T
Br J Haematol; 2006 Aug; 134(4):406-16. PubMed ID: 16822283
[TBL] [Abstract][Full Text] [Related]
23. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
24. HLA-restricted cell-mediated cytotoxicity directed against male specific (H-Y) antigen after acute rejection of an HLA-identical sibling kidney.
Pfeffer PF; Sødal G; Thorsby E
Scand J Urol Nephrol Suppl; 1981; 64():72-8. PubMed ID: 6216585
[TBL] [Abstract][Full Text] [Related]
25. Minors come of age: Minor histocompatibility antigens and graft-versus-host disease.
Chao NJ
Biol Blood Marrow Transplant; 2004 Apr; 10(4):215-23. PubMed ID: 15077220
[TBL] [Abstract][Full Text] [Related]
26. A multiplex bead array analysis to monitor donor-specific cytokine responses after withdrawal of immunosuppression in HLA-identical living related kidney transplant patients.
Gerrits JH; van de Wetering J; van Beelen E; Claas FH; Weimar W; van Besouw NM
Transplant Proc; 2009 Jun; 41(5):1577-82. PubMed ID: 19545683
[TBL] [Abstract][Full Text] [Related]
27. Minor H antigen matches and mismatches are equally distributed among recipients with or without complications after HLA identical sibling renal transplantation.
Dierselhuis MP; Spierings E; Drabbels J; Hendriks M; Alaez C; Alberú J; Alvarez MB; Burlingham W; Campos E; Christiaans M; Claas F; Fasano ME; Gerbase-Delima M; Gervais T; Gorodezky C; Larriba J; Lardy NM; Latinne D; Morales-Buenrostro LE; Moreno MJ; Oguz F; Opelz G; Sergeant R; Tambutti M; Teper S; Tilanus M; Turkmen A; Warrens AN; Weimar W; Goulmy E
Tissue Antigens; 2013 Nov; 82(5):312-6. PubMed ID: 24116658
[TBL] [Abstract][Full Text] [Related]
28. [The significance of mixed lymphocyte culture and mitogen-stimulated culture for kidney transplantation (author's transl)].
Hajek-Rosenmayr A; Wolf A
Wien Klin Wochenschr; 1981 Jul; 93(14):457-60. PubMed ID: 6455859
[TBL] [Abstract][Full Text] [Related]
29. The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.
Vogt MH; van den Muijsenberg JW; Goulmy E; Spierings E; Kluck P; Kester MG; van Soest RA; Drijfhout JW; Willemze R; Falkenburg JH
Blood; 2002 Apr; 99(8):3027-32. PubMed ID: 11929796
[TBL] [Abstract][Full Text] [Related]
30. The relevance of minor histocompatibility antigens in solid organ transplantation.
Dierselhuis M; Goulmy E
Curr Opin Organ Transplant; 2009 Aug; 14(4):419-25. PubMed ID: 19444105
[TBL] [Abstract][Full Text] [Related]
31. [The importance of a good HLA match].
Leivestad T; Thorsby E
Nord Med; 1994; 109(6-7):188-90, 201. PubMed ID: 8015913
[TBL] [Abstract][Full Text] [Related]
32. KIR/HLA ligand incompatibility in kidney transplantation.
Kunert K; Seiler M; Mashreghi MF; Klippert K; Schönemann C; Neumann K; Pratschke J; Reinke P; Volk HD; Kotsch K
Transplantation; 2007 Dec; 84(11):1527-33. PubMed ID: 18091530
[TBL] [Abstract][Full Text] [Related]
33. Donor-reactive cytokine profiles after HLA-identical living-related kidney transplantation.
Gerrits JH; van de Wetering J; Drabbels JJ; Claas FH; Weimar W; van Besouw NM
Nephrol Dial Transplant; 2008 Jun; 23(6):2016-23. PubMed ID: 18156655
[TBL] [Abstract][Full Text] [Related]
34. Role of minor histocompatibility antigens in renal transplantation.
Heinold A; Opelz G; Scherer S; Ruhenstroth A; Laux G; Doehler B; Tran TH
Am J Transplant; 2008 Jan; 8(1):95-102. PubMed ID: 18093280
[TBL] [Abstract][Full Text] [Related]
35. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
36. The HLA system in blood transfusion.
Navarrete CV
Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):511-32. PubMed ID: 11102274
[TBL] [Abstract][Full Text] [Related]
37. A study of HLA-G polymorphism and linkage disequilibrium in renal transplant patients and their donors.
Pirri A; Contieri FC; Benvenutti R; Bicalho Mda G
Transpl Immunol; 2009 Jan; 20(3):143-9. PubMed ID: 18926911
[TBL] [Abstract][Full Text] [Related]
38. Improving the outcome of unrelated donor stem cell transplantation by molecular matching.
Shaw BE; Madrigal JA; Potter M
Blood Rev; 2001 Dec; 15(4):167-74. PubMed ID: 11792117
[TBL] [Abstract][Full Text] [Related]
39. [Histocompatibility tests in a transplantation program].
de-Leo-Cervantes C
Rev Invest Clin; 2005; 57(2):142-6. PubMed ID: 16524052
[TBL] [Abstract][Full Text] [Related]
40. Multiplex genotyping of human minor histocompatibility antigens.
Pietz BC; Warden MB; DuChateau BK; Ellis TM
Hum Immunol; 2005 Nov; 66(11):1174-82. PubMed ID: 16571418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]